Group items tagged

Starting from January 2024, it will be compulsory for medicine suppliers in the NHS supply chain in England to submit an Evergreen Sustainable Supplier Assessment each year. Suppliers who fail to submit the sustainability assessment will not be placed on medicines contracts, said NHS England. The NHS has taken this move as part of its ambition to reach carbon net zero by 2045. The Evergreen Sustainable Supplier Assessment is a self-assessment and reporting tool for suppliers to share sustainability information with the NHS. Chris McAleer, medicines net zero project delivery manager at NHS England, announced this new rule at the Guild of Healthcare Pharmacists' Procurement and Distribution Interest Group Autumn Symposium held in Birmingham on 2 November 2023.

In a bid to revolutionise healthcare in the UK, the Reform Party has announced ambitious plans to offer tax incentives to pharmacies. This move comes despite record extra funding in recent years, which has failed to halt a decline in NHS healthcare outcomes. The party argues that while healthcare remains free at the point of delivery, significant reforms are essential to enhance results and eliminate waiting lists. Central to the Reform Party's strategy is a set of critical reforms aimed at addressing NHS challenges within the first 100 days. The implementation of tax breaks for pharmacies is intended to enhance accessibility and alleviate pressure on NHS resources.

In a remarkable turn of events, the NHS App has emerged as a financial saviour for the National Health Service, slashing costs by over £1 million in the last year alone. The revelation comes as a testament to the app's growing significance in streamlining patient communication and service delivery. Throughout the fiscal year 2023/24, a staggering 22.5 million messages traversed the NHS App, a feat previously reliant on traditional methods like text messages or letters. This monumental shift not only signifies a boon for efficiency but also heralds substantial savings, with each text message costing an average of 5p. Drastically reducing these expenses has amounted to a commendable £1.1 million in savings, marking a pivotal milestone in NHS expenditure management.

In a strategic move to enhance healthcare delivery, the NHS has announced plans to intensify the utilisation of virtual wards under the the Urgent and Emergency Care Recovery Plan. The NHS virtual wards are aimed to reduce avoidable hospital admissions across England. This follows a comprehensive analysis revealing significant benefits from virtual wards over the past year. "Virtual wards offer a transformative approach to healthcare delivery, allowing patients to receive medical care from the comfort of their own homes," remarked NHS national director for urgent and emergency care, Sarah-Jane Marsh. "This initiative not only reduces the burden on hospital resources but also ensures that patients receive timely and personalised care."

In a delightful announcement, the University of Brighton has honoured NHS England's Chief Pharmaceutical Officer, David Webb with its prestigious Doctor of Science honorary degree Webb's award is a highlight of the university's graduation ceremony which celebrated the graduation of over 3,400 undergraduate and postgraduate students from 92 countries at the Brighton Centre this week. The accolade recognises Webb's transformative work in the pharmacy services within the NHS, highlighting the profound impact his contributions have had on delivery of healthcare across the UK. Under Webb's leadership, significant advancements have been made in integrating pharmacy into NHS care pathways, improving patient outcomes, and enhancing the role of pharmacists and pharmacy technicians in the healthcare system. Webb expressed his honour stating, "I am delighted to receive the honorary award of Doctor of Science from the University of Brighton in recognition of both my contribution to pharmacy in the NHS"

The government has decided to refresh the NHS workforce plan, prioritising on shifting care from hospitals and into the community. The revised plan, expected to be unveiled in the summer 2025, aims to ensure the workforce is used effectively to support the delivery of the upcoming 10-Year Health Plan. Health secretary Wes Streeting explained the need to revise the plan citing Lord Darzi's report, which highlighted the dire state of the NHS, including that "too many people end up in hospital because there aren't the resources in the community to reach patients earlier." "Our 10 Year Health Plan will deliver 3 big shifts in the focus of healthcare: from hospital to community, analogue to digital, and sickness to prevention. "We will refresh the NHS workforce plan to fit the transformed health service we will build over the next decade, so the NHS has the staff it needs to treat patients on time again," Streeting said.

Wes Streeting's speech at the Labour Party Conference 2024 outlines several key health and social care reforms, which hold significant implications for community pharmacy in England. His focus on reforming and rebuilding the NHS to ensure fair, universal access to care, with prevention and early intervention at its core, presents both opportunities and challenges for community pharmacy. Here are the potential implications: 1. Prevention Focus Streeting's vision of a shift from a reactive, hospital-based model to a preventive healthcare system presents a promising future for community pharmacies. These changes could significantly reduce pressures on GPs and hospitals, integrating pharmacies more closely into primary care networks and enhancing their role in preventive care. 2. Digital Transformation The move from an "analogue to digital" NHS could see community pharmacies adopting more digital tools and systems for service delivery. This would likely involve greater use of digital prescribing, telehealth consultations, and AI-driven services. Pharmacies will need to invest in digital infrastructure and ensure that pharmacy professionals are trained to operate within a more tech-centric environment. 3. Reform and Redistribution of Services Streeting's plans to extend choice and equitable access to services mean that community pharmacies could become integral to providing care in underserved or disadvantaged areas. With a focus on decentralising healthcare and bringing it closer to local communities, community pharmacies could play a more significant role in supporting healthcare delivery in areas where GP services are stretched. This may include expanding access to pharmacy services in the most deprived areas, aligning with Labour's emphasis on addressing health inequalities.

Global instant logistics leader, Zipline is partnering with UK drone delivery startup, Apian Aero to launch a drone delivery programme of critical medical supplies for the Northumbria Healthcare NHS Foundation Trust. The new service, expected to begin in the autumn of 2024, will see delivery of medical supplies to hospitals, GPs and care homes, using electric, autonomous drones. Zipline announced the partnership on Sunday, and said drone delivery service will help provide timely access to prescription medicines, wound care products, joint replacement implants, and other frequently ordered medical products, which could allow healthcare providers to reduce the number of cancelled procedures, and thus decrease wait times. Also, the expansion of the programme will help in creating local job opportunities in the region, it added.

A massive global technology outage on Friday has disrupted essential services, including healthcare, airlines, banks, and broadcasters worldwide. The outage, attributed to a flawed update from cybersecurity firm CrowdStrike, has also affected the National Health Service (NHS) in the UK, with several hospitals and GP practices losing access to their computer systems. Community pharmacies are also facing significant disruptions. Services such as accessing prescriptions from GPs and medicine deliveries have been affected, causing inconvenience to patients and healthcare providers. An NHS spokesperson said: "The NHS is aware of a global IT outage and an issue with EMIS, an appointment and patient record system, which is causing disruption in the majority of GP practices." The spokesperson assured that the NHS has long-standing measures in place to manage such disruptions, including the use of paper patient records and handwritten prescriptions, and the usual phone systems to contact GPs.

The new 'How to Involve and Engage Patients on Digital Health Tech Innovation' learning module has been created specifically to support the development and delivery of patient-centric technologies, at a time of critical digital transformation in the NHS. The foundation level module will be freely available at www.orcha-digitalhealthacademy.com and on the Health Education England NHS Learning Hub (learninghub.nhs.uk). No training previously exists on conducting effective patient and public involvement and engagement (PPIE), leading to wasted resource on unsuitable technologies at a time when the healthcare system simply cannot afford it. The module aims to educate innovators who are creating new technology, and the clinicians who are prescribing these solutions. Crucially, the module also provides valuable support to the 500 NHS clinicians who are on the Clinical Entrepreneur Programme. The module is an introduction to the first evidence-based framework for PPIE, launched by the University of Plymouth, the AHSN Network (the national voice of the 15 academic health science networks in England) and Boehringer Ingelheim UK & Ireland. It helps to fast-track learning for the EnACT principles described in the framework, outlining how to involve patients in product innovation and critical issues such as data privacy, intellectual property, inclusivity, reimbursement, useability, and recruitment of patients.

The new Labour government has pledged to deliver an extra 40,000 NHS appointments, operations and diagnostics every week, equivalent to two million a year, to tackle the ongoing waiting list crisis. It aims to ensure that 92 per cent of patients start routine hospital treatment within 18 weeks by the end of this parliament - a target that has not been met for nearly a decade. However, a new analysis by healthcare consultancy CF (Carnall Farrar) and the NHS Confederation has revealed that these extra appointments alone will not be enough to achieve the 18-week Referral To Treatment (RTT) target by 2028/29. The study estimates that 40,000 extra appointments per week would deliver only about 15 per cent of the additional activity required to hit the 18-week target, assuming demand continues to grow at current rates and care delivery remains unchanged. While the report acknowledged that increasing capacity is a positive step, it stresses that further reforms and transformations in care pathways are necessary to bridge the gap.

The NHS is facing a range of long term challenges which needs to be countered with prevention, enhance personalised care and sustainable performance, health and social care secretary Sajid Javid said on Tuesday (March 8). In his speech on healthcare reform at the Royal College of Physicians in London, he said: "We face some long-term challenges: how to keep the NHS focused on delivery while futureproofing it for changing demographics and disease; how to meet rising patient expectations and address the injustices of widespread disparities; and how to deal with an unsustainable financial trajectory while backing the brilliant people who work in health and care." Javid emphasised on three key points for healthcare reform - prevention, personalisation and performance. He said, prevention is not just about building a 'national hospital service' but a true 'National Health Service'.

Pharmacy professionals to be included as key stakeholders in the implementation, delivery and evaluation of a wide range of genomic services, said the Royal Pharmaceutical Society (RPS). RPS's statement has been developed in collaboration with pharmacy organisations who have co-badged the report, such as the British Oncology Pharmacy Association, the UK Clinical Pharmacy Association, Association of Pharmacy Technicians and the College of Mental Health Pharmacy. It looks at current and future roles for pharmacy professionals in genomic medicine across many aspects of practice such as person-centred care and collaboration, professional practice, education, leadership, management and research. Pharmacists and pharmacy technicians in the UK have already established roles in the application of genomic medicine in some areas of practice, such as antimicrobial stewardship and infectious diseases, and the management of certain genetic conditions, such as cystic fibrosis. The society believes, the current role of pharmacy professionals in genomics can be expanded upon in the future to both lead and support many relevant aspects of genomic implementation. These are described across all healthcare sectors, within the Genome UK strategy produced by the UK Government, and within the implementation plans published in England, Scotland and Wales. Lead for Pharmacogenomics at RPS Sophie Harding said: "Pharmacy professionals are the gatekeepers of medication safety and efficacy across all areas of healthcare. They are skilled at interpreting complex scientific data and use evidence-based medicine to maximise the benefits of treatments for patients, whilst supporting shared decision-making with patients and the multidisciplinary team.

The latest GP Patient Survey 2024 by the National Health Services (NHS) involving 2.56 million patients has revealed encouraging insights into patient experiences with pharmacy services across England. Along with pharmacies, GPs, and dentistry services were also surveyed highlighting the vital role these services provide in healthcare delivery. Among the key findings, 89.3 per cent of respondents reported utilising at least one pharmacy service in the past year, highlighting the widespread reliance on these facilities. Of those who used pharmacy services, an overwhelming majority of 86.8 per cent expressed satisfaction with their experience. The survey identified 'picking up prescriptions' as the most commonly accessed service, with 75.8 per cent of patients utilising this facility.

The College of General Dentistry, in partnership with Haleon, has unveiled a new report outlining recommendations from oral health professionals on how to best improve the provision of preventative oral care. The report includes insight-driven recommendations to bridge the gap between the intentions and practical delivery of this care. Drawing on input from UK oral health professionals, the report highlighted the need for redesigned NHS contracts that would provide more time and financial support in giving preventative oral care advice. It also called for increased resources to offer consistent preventative oral healthcare education to combat misinformation and promote healthier habits. Other key recommendations from the report include: Working with the government to update the Delivering Better Oral Health Toolkit to make it simpler and more user-friendly. Launching a national communications campaign to tackle misinformation about oral care Encouraging businesses to include dental cover in their employee assistance programmes

Skelmersdale-based online pharmacy Chemist4U has secured a £12 million investment from Pitalia Capital, an equity investment company led by Anil Pitalia. Chemist4U is part of JCCO Healthcare, which also houses the weight management platform myBMI. Anil Pitalia is a health enthusiast, who heads SpaMedica, a company providing cataract surgery to the NHS. This investment will propel the group's expansion, with John Davies, Managing Partner of Pitalia Capital, joining the board, the company said. Moreover, it will facilitate the extension of services by myBMI in the realm of weight management. "Our goal is for Chemist4U to emerge as one of the largest NHS dispensing facilities in the country, while also providing vital support to our partners through our rapidly expanding outsourced dispensing services division," said said James O'Loan, Chief Executive Officer of both Chemist4U and myBMI, who joined Chemist4U as a superintendent pharmacist in 2012 before becoming CEO in 2018. Meanwhile, Anil Pitalia, Head of Pitalia Capital based in Bolton, cited the compelling growth potential as the driving force behind his investment in Chemist4U's next-day medicine delivery service.

Three leading healthcare bodies in Scotland have called for action to reduce the environmental impact caused by medicine prescribing. The Academy of Medical Royal Colleges and Faculties in Scotland, Royal Pharmaceutical Society and the Royal College of General Practitioners Scotland have all urged policymakers to enable a more sustainable approach to prescribing. This includes prioritising the introduction of electronic prescribing across the NHS, introducing the requirement for an environmental impact in NHS medicines procurement and improving the availability of data about the environmental impact of medicines. "We call on Scottish government, including the chief medical officer, to enable the delivery of a realistic medicine approach to prescribing by developing a supportive infrastructure for green social prescribing across Scotland," said the healthcare professionals in a joint statement. They have called on the pharmaceutical industry to make information about the environmental impact of medicines readily available in a standardised data format.

Rowlands Pharmacy has joined hands with healthcare software company HasHealth for an enhanced digital proposition to facilitate seamless delivery of a raft of clinical services including flu and travel vaccinations. The new system is now available across 400 Rowlands pharmacies across the UK. The partnership comes as Rowlands Pharmacy strives to provide patients with a seamless booking experience whilst minimising time-consuming administration for pharmacy staff, with its waiting list, medical pre-screen questionnaires and resource management capabilities, the company said in a statement. HasHealth offers a virtual healthcare software solution that allows community pharmacies to schedule, manage, and communicate with patients easily online. It combines its cutting-edge video technology with booking and management software, which can be adapted to any clinical service. Nigel Swift, managing director at Rowlands Pharmacy, commented: "We pride ourselves on listening to our staff, based on feedback we knew we could do better with our digital proposition for clinical services and flu vaccinations in particular.

At the UK Covid-19 Inquiry's Module 3 hearings on 10 September, the National Pharmacy Association (NPA) highlighted that community pharmacy was "often overlooked and under-recognised" during the pandemic. Lawyer Lee John-Charles, speaking on behalf of the NPA, told the Inquiry that despite the central role played by community pharmacy in the delivery of NHS care throughout the pandemic, community pharmacists and their teams were "not given comparable treatment to other frontline healthcare workers." The NPA criticised the initial exclusion of pharmacy workers from the Life Assurance Scheme for frontline workers in England, calling on the Inquiry to investigate this notable omission. The NPA also pointed out that community pharmacies were forced to source and fund their own personal protective equipment (PPE) as it was not initially available to them through the NHS.

NPA Insurance, a wholly owned subsidiary of the National Pharmacy Association (NPA), has updated its professional indemnity policy for locum pharmacists to better support their expanding roles in healthcare. The enhanced policy now includes private and NHS prescribing cover for weight loss and other areas of competence, which is available for locums working in pharmacy, general practice and hospital settings. Policyholders will benefit from an extended range of cover, which includes, as standard, the delivery of the NHS Pharmacy First service, the expanded pharmacy contraception service, and the re-launched hypertension case-finding service. Moreover, NPA Insurance has removed charges for vaccine administration, including COVID-19, flu, and travel. Locum pharmacists will also have access to NPA Insurance's award-winning claims team as part of the new policy.